Réaction #792216

ord-6f6106b0e78c4122a50bfaefaf7e236d

Équation de réaction

O
water
CC1(C)OB(c2coc(-c3cccnc3)c2)OC1(C)C
3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-furyl]pyridine
Brc1cccc(-c2ncccn2)n1
2-(6-bromopyridin-2-yl)pyrimidine
O=C([O-])[O-].[Na+].[Na+]
sodium carbonate
c1cnc(-c2cccc(-c3coc(-c4cccnc4)c3)n2)nc1
2-{6-[5-(pyridin-3-yl)-3-furyl]pyridin-2-yl}pyrimidine
Rendement 50.0%

Solvants

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    AutreThe reaction mixture was degassed in an ultrasonic bath under argon
  2. 2
    Températureheated
  3. 3
    Températureto reflux temperature
  4. 4
    Températureunder reflux for 8 hours
  5. 5
    Autreat room temperature
  6. 6
    Autreovernight
  7. 7
    Extractionextracted with dichloromethane
  8. 8
    Lavagewashed with 100 ml of water
  9. 9
    Séchagedried over MgSO4
  10. 10
    FiltrationThe mixture was then filtered
  11. 11
    Concentrationconcentrated under reduced pressure on a rotary evaporator
  12. 12
    AutreChromatographic purification

Mode opératoire

400 mg (1.38 mmol) of 3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-furyl]pyridine and 347 mg (1.38 mmol) of 2-(6-bromopyridin-2-yl)pyrimidine were initially charged in 20 ml of dioxane, and 3.46 ml of a 2 molar aqueous sodium carbonate solution were added. The reaction mixture was degassed in an ultrasonic bath under argon and then heated to reflux temperature, and, at 80° C., 48.0 mg (42.0 μmol) of tetrakis(triphenylphosphine)palladium(0) were added. The reaction mixture was stirred under reflux for 8 hours and then at room temperature overnight. The mixture was then poured into 100 ml of water and extracted with dichloromethane. The light-yellow organic phases were combined, washed with 100 ml of water and then dried over MgSO4. The mixture was then filtered and concentrated under reduced pressure on a rotary evaporator. Chromatographic purification gave 206 mg (50% of theory) of 2-{6-[5-(pyridin-3-yl)-3-furyl]pyridin-2-yl}pyrimidine.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US09173396B2uspto-grants-2015_11